These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 1703682)

  • 1. Conversion of liver allograft recipients from cyclosporine to FK 506-based immunosuppression: benefits and pitfalls.
    Fung JJ; Todo S; Tzakis A; Demetris A; Jain A; Abu-Elmaged K; Alessiani M; Starzl TE
    Transplant Proc; 1991 Feb; 23(1 Pt 1):14-21. PubMed ID: 1703682
    [No Abstract]   [Full Text] [Related]  

  • 2. Positive crossmatch in primary human liver allografts under cyclosporine or FK 506 therapy.
    Takaya S; Duquesnoy R; Iwaki Y; Demetris J; Yagihashi A; Bronsther O; Iwatsuki S; Starzl TE
    Transplant Proc; 1991 Feb; 23(1 Pt 1):396-9. PubMed ID: 1703691
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficiency of FK 506 and CyA to prevent acute cellular rejection of pig liver allografts.
    Lautenschlager I; Höckerstedt K; Mäkisalo H; Orko R; Taskinen E
    Transplant Proc; 1991 Aug; 23(4):2233-5. PubMed ID: 1714650
    [No Abstract]   [Full Text] [Related]  

  • 4. A study of the contrasting effects of cyclosporine, FK 506, and rapamycin on the suppression of allograft rejection.
    Morris RE; Wu J; Shorthouse R
    Transplant Proc; 1990 Aug; 22(4):1638-41. PubMed ID: 1697111
    [No Abstract]   [Full Text] [Related]  

  • 5. Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications.
    Fung JJ; Todo S; Jain A; McCauley J; Alessiani M; Scotti C; Starzl TE
    Transplant Proc; 1990 Feb; 22(1):6-12. PubMed ID: 1689901
    [No Abstract]   [Full Text] [Related]  

  • 6. Pancreaticoduodenal allotransplantation with the use of FK 506, cyclosporine, and triple-regimen immunosuppression.
    Imai K; Sato K; Takishima T; Nakayama Y; Osakabe T; Yokota K; Yamagishi K; Uchida H; Hiki Y
    Transplant Proc; 1990 Aug; 22(4):1655-7. PubMed ID: 1697117
    [No Abstract]   [Full Text] [Related]  

  • 7. Significance of pancreatic allograft rejection in swine abdominal organ cluster transplantation.
    Kobayashi N; Sakagami K; Takasu S; Inagaki M; Hasuoka H; Yagi T; Onoda T; Matsuno T; Saito S; Kawamura T
    Transplant Proc; 1991 Feb; 23(1 Pt 1):635-9. PubMed ID: 1703707
    [No Abstract]   [Full Text] [Related]  

  • 8. Conversion of liver allograft recipients from cyclosporine A to FK 506 immunosuppressive therapy.
    Ben-Ari Z; Mor E; Shaharabani E; Bar-Nathan N; Shapira Z; Tur-Kaspa R
    Transplant Proc; 2000 Jun; 32(4):709-10. PubMed ID: 10856553
    [No Abstract]   [Full Text] [Related]  

  • 9. Prognostic factors for successful conversion from cyclosporine to FK 506-based immunosuppressive therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group.
    Klintmalm GB; Goldstein R; Gonwa T; Wiesner RH; Krom RA; Shaw BW; Stratta R; Ascher NL; Roberts JW; Lake J
    Transplant Proc; 1993 Feb; 25(1 Pt 1):641-3. PubMed ID: 7679828
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of FK 506 and cyclosporine on heart allograft survival in rats.
    Goto S; Stepkowski SM; Kahan BD
    Transplant Proc; 1991 Feb; 23(1 Pt 1):529-30. PubMed ID: 1703700
    [No Abstract]   [Full Text] [Related]  

  • 11. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
    Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
    Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of FK 506 on heart allograft survival in highly sensitized recipient rats in comparison with cyclosporine.
    Jiang H; Takahara S; Takano Y; Li D; Kyo M; Valdivia LA; Kokado Y; Ishibashi M; Sonoda T
    Transplant Proc; 1991 Feb; 23(1 Pt 1):540-1. PubMed ID: 1703702
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of short-term immunosuppressive therapy with cyclosporine and FK 506 in small-bowel transplantation.
    Lee KK; Stangl MJ; Todo S; Langrehr JM; Hoffman A; Starzl TE; Schraut WH
    Transplant Proc; 1990 Dec; 22(6):2485-6. PubMed ID: 1702239
    [No Abstract]   [Full Text] [Related]  

  • 14. Tacrolimus (FK 506) for rescue of chronic rejection following orthotopic liver transplantation.
    Sher LS; Cosenza CA; Petrovic LM; Rojter S; Hoffman A; Lopez RR; Meehan M; Pan SH; Vierling J; Makowka L
    Transplant Proc; 1996 Apr; 28(2):1011-3. PubMed ID: 8623212
    [No Abstract]   [Full Text] [Related]  

  • 15. FK 506 rescue therapy for intractable liver allograft rejection.
    Wong P; Devlin J; Gane E; Ramage J; Portmann B; Williams R
    Transpl Int; 1994; 7 Suppl 1():S70-6. PubMed ID: 11271339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphological and immunological analysis of rats with long-term-surviving limb allografts induced by a short course of FK 506 or cyclosporine.
    Kuroki H; Ishida O; Daisaku H; Fukuhara K; Hatano E; Murakami T; Ikuta Y; Matsumoto AK; Akiyama M
    Transplant Proc; 1991 Feb; 23(1 Pt 1):516-20. PubMed ID: 1703697
    [No Abstract]   [Full Text] [Related]  

  • 17. Cyclosporine and tacrolimus: a comparison of immunosuppressants used for liver transplantation.
    Shultz SL; Meriney DK
    Dimens Crit Care Nurs; 1996; 15(4):187-97. PubMed ID: 8717641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histopathology of human renal allograft rejection under FK 506: a comparison with cyclosporine.
    Demetris AJ; Banner B; Fung J; Shapiro R; Jordan M; Starzl TE
    Transplant Proc; 1991 Feb; 23(1 Pt 2):944-6. PubMed ID: 1703360
    [No Abstract]   [Full Text] [Related]  

  • 19. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation.
    Woodle ES; Bruce DS; Josephson M; Newell KA; Piper JB; Millis JM; Cronin D; Whitman G; Ruebe M; Thistlethwaite JR
    Clin Transplant; 1996 Aug; 10(4):323-32. PubMed ID: 8884103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FK 506--an investigational immunosuppressant.
    Med Lett Drugs Ther; 1991 Oct; 33(854):94. PubMed ID: 1716722
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.